Cyclic rifaximin therapy effectively prevents the recurrence of symptoms after exacerbation of symptomatic uncomplicated diverticular disease: a retrospective study
Saved in:
Main Authors: | Anna M. Pietrzak, Adam Dziki, Tomasz Banasiewicz, Jarosław Reguła |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2019-03-01
|
Series: | Gastroenterology Review |
Subjects: | |
Online Access: | https://www.termedia.pl/Cyclic-rifaximin-therapy-effectively-prevents-r-nthe-recurrence-of-symptoms-after-exacerbation-r-nof-symptomatic-uncomplicated-diverticular-disease-a-retrospective-study,41,36011,1,1.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of gut microbiota in the pathogenesis of diverticular disease: where are we now?
by: Antonio Tursi, et al.
Published: (2024-12-01) -
The effect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a “real-life” study
by: Andrzej Moniuszko, et al.
Published: (2017-06-01) -
Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient Practice
by: O. S. Shifrin, et al.
Published: (2020-04-01) -
Efficacy of rifaximin in the treatment of chronic relapsing diverticulitis
by: S. I. Achkasov, et al.
Published: (2012-04-01) -
Nueva clasificación endoscópica y factores de riesgo asociados a la enfermedad diverticular del colon
by: Misdrialis Martinez Romero, et al.
Published: (2024-05-01)